Eritel-Beta 25 Tablets are a combination medication that includes Metoprolol Succinate (Prolonged Release) and Telmisartan. This formulation is designed to support cardiovascular health and blood pressure management under the guidance of a healthcare professional. By combining two well-established medications with complementary mechanisms, this product offers a comprehensive approach to managing heart-related conditions.
Metoprolol Succinate belongs to a class of medications known as beta-blockers. It works by slowing down the heart rate and reducing the force of contraction of the heart muscle. This helps decrease the workload on the heart and improves its efficiency. The prolonged-release (PR) formulation ensures that the medication is released gradually over time, providing sustained therapeutic action throughout the day.
Telmisartan, on the other hand, is an angiotensin II receptor blocker (ARB). It works by relaxing blood vessels, allowing blood to flow more easily. By blocking the action of angiotensin II, a substance that causes blood vessels to constrict, Telmisartan helps reduce vascular resistance and supports the regulation of blood pressure.
When used together in Eritel-Beta 25 Tablets, these two components provide a dual mechanism of action. Metoprolol addresses heart rate and cardiac workload, while Telmisartan focuses on blood vessel relaxation and pressure regulation. This combination can be beneficial for individuals who require multi-faceted cardiovascular management as part of their treatment plan.
Eritel-Beta 25 Tablets are typically prescribed as part of a broader strategy that may include lifestyle modifications such as maintaining a balanced diet, engaging in regular physical activity, managing stress, and reducing sodium intake. The medication is usually taken once daily, or as directed by a healthcare provider, and should be consumed at the same time each day for optimal results.
The prolonged-release formulation of Metoprolol ensures steady medication levels in the body, which may help improve treatment adherence and consistency. The tablet should be swallowed whole and not crushed or chewed, as this may interfere with the controlled-release mechanism.
This medication should only be used under medical supervision. Patients are advised to follow the prescribed dosage and not discontinue use abruptly without consulting their doctor, as sudden withdrawal may have adverse effects. Regular monitoring of blood pressure and heart rate may be recommended during treatment.
Individuals with pre-existing conditions such as asthma, diabetes, kidney or liver disorders, or heart rhythm issues should inform their healthcare provider before starting this medication. It is also important to disclose all other medications and supplements being taken to avoid potential interactions.
Manufactured under stringent quality standards, Eritel-Beta 25 Tablets are packaged securely to maintain their effectiveness and stability. The strip packaging protects the tablets from environmental factors such as moisture and light.
When used appropriately and as prescribed, Eritel-Beta 25 Tablets can play an important role in supporting cardiovascular health and maintaining stable blood pressure levels. Combining medication with a healthy lifestyle is essential for achieving the best outcomes.